Chemical Research in Toxicology
Article
Thermo Scientific equipped with a Thermo Accela Pump, an Accela
autosampler, and an Accela photodiode array detector. The data were
processed using Xcalibur software. HPLC purification was performed
using an Agilent 1200 Series LC system. 1H NMR spectra were
recorded on Bruker Avance DMX 200 and Bruker Avance 500
spectrometers at 295 K in 400 μL of either CD3OD (isotope purity
>99.8%) or D2O (isotope purity: 99.95%).
Chemical Synthesis. 8-Bromo-2′-deoxyguanosine (8-Br-dGuo,
1). dGuo (4 g, 15 mmol) was suspended in a mixture of water (40 mL)
and acetonitrile (160 mL). N-Bromo-succinimide (4g, 22.5 mmol) was
added at 0 °C in three portions. The reaction mixture was stirred for
30 min at room temperature and subsequently concentrated under
reduced pressure. This material was then dissolved in acetone (80 mL)
and stirred for 2 additional hours at room temperature. The resulting
to add to C8 of guanine upon one electron oxidation of double
stranded (ds) DNA.
Thus, in the present work, attempts have been made to
determine if small polyamine molecules could also be involved
in such a reaction. Polyamines are organic cations localized in
the nucleus of all eukaryotic cells17 at millimolar concentration
ranges. They are biosynthesized by enzymatic decarboxylation
of the amino acids ornithine and arginine by ornithine
decarboxylase (ODC).18 It has been proposed that due to
their affinity for anionic sites of nucleic acids, the polyamines’
main role is to stabilize and condense DNA.19 They are also
involved in several essential metabolic processes, such as
regulation of RNA transcription, specific gene expression, and
the progression of the cell cycle.18 They play a role in cell
growth and cancer, and an increase in their cellular
concentration correlates with a loss of cell proliferation control
and could consequently lead to neoplesia.18 Furthermore,
polyamines are present in a high concentration in several
biological fluids in patients suffering from different types of
cancer.20 The assessment of their levels in urine, blood, or
cerebrospinal liquid can be informative as a marker of tumor
growth in treated patients. It has been used for the prediction of
relapse as well as in the follow-up of chemotherapy
efficiency.21,22 For these reasons, polyamines are a potential
target in cancer treatment, and various inhibitors of their
biosynthesis have been developed. The most studied is α-
difluoromethylornithine, which is an irreversible inhibitor of
ODC. Polyamine oxidase, an enzyme involved in the
catabolism of polyamines, is also considered as an interesting
outlook in the development of antineoplasic drugs.23 Finally,
recent studies have highlighted the interest of using a low
polyamine diet in addition to chemotherapy.24 Therefore, the
link between polyamines and cancer has been widely described.
Nevertheless, the exact mechanism in which the upregulation of
their metabolism could be implicated in carcinogenesis is still
unknown.
precipitate was collected by vacuum filtration with a Buchner funnel.
̈
The filtrate was rinsed twice with cold acetone and dried under
vacuum to provide 3.85 g (11.1 mmol, 74%) of a slightly pink powder.
This compound was used for the next reaction steps without further
purification. 1H NMR (D2O, 200 MHz, δ): 2.13 (ddd, 1H, J = 2.3, 6.5,
13.6 Hz, H2′′), 3.07 (ddd, 1H, J = 6.3, 8.1, 13.6 Hz, H2′), 3.64 (dd,
1H, J = 4.2, 12.0 Hz, H5′′), 3.75 (dd, 1H, J = 3.4, 12.0 Hz, H5′), 3.89−
3.95 (m, 1H, H4′), 4.48−4.54 (m, 1H, H3′), 6.30 (dd, 1H, J = 6.5, 8.1
Hz, H1′).
8-((4-Aminobutyl)amino)-2′-deoxyguanosine (8-put-dGuo, 2). 8-
Br-dGuo (1) (69 mg, 0,2 mmol) and 1,4 diaminobutane (100 μL, 1
mmol) were dissolved in DMSO (1.2 mL). Triethylamine (135 μL, 1
mmol) was added, and the reaction mixture was heated for 15 h at 110
°C. According to HPLC-UV monitoring, the substitution reaction
afforded 25% of 8-put-dGuo. The crude material was diluted 10 times
in water, neutralized with HCl, and then purified by C18 reverse phase
HPLC. The elution was performed using a C18 column (Interchim
uptisphere 5 μm ODB 250·4.6 mm), at a flow rate of 1 mL/min, with
0.1% trifluoroacetic acid as the mobile phase (eluent A) and a linear
gradient of acetonitrile (eluent B, 0−14% over 21 min). The product
which eluted at 15 min (k′ = 3.41) was collected, concentrated, and
lyophilized. 1H NMR (D2O, 500 MHz, δ): 1.70−1.78 (m, 4H,
HputB,C), 2.26 (ddd, 1H, J = 1.8, 6.6, 14.5 Hz, H2′′), 2.77 (ddd, 1H, J =
6.6, 8.4, 14.5 Hz, H2′), 3.02−3.08 (m, 2H, H putD), 3.34−3.42 (m, 2H,
HputA), 3.88 (dd, 1H, J = 2.3, 12.4 Hz, H5′′), 3.92 (dd, 1H, J = 2.1,
12.4 Hz, H5′), 4.12−4.14 (m, 1H, H4′), 4.63−4.65 (m, 1H, H3′), 6.31
+
The aim of our study is to investigate the possible formation
of adducts between polyamines and 2′-deoxyguanosine in
dsDNA following a one electron oxidation reaction. For such a
purpose, we have designed a chemical synthesis of the
potentially generated DNA adducts involving either putrescine,
spermine, or spermidine. In addition, we have optimized a
HPLC-MS/MS method to quantify these adducts in DNA
subsequent to enzymatic digestion into corresponding free
nucleosides. Using such a strategy, we have demonstrated that
polyamine-C8-guanine adducts could be generated following a
type I photosensitization reaction involving riboflavin and UVA,
a well-known approach to generate guanine radical cations25 in
dsDNA.
(dd, 1H, J = 6.6, 8.4 Hz, H1′). MALDI-HRMS m/z for C14H24N7O4
([M + H]+): calcd 354.1890; found 354.1883.
8-((3-((4-Aminobutyl)amino)propyl)amino)-2′-deoxyguanosine
and 8-((4-((3-aminopropyl)amino)butyl)amino)-2′-deoxyguano-
sine (8-spd-dGuo 3a and 3b). The synthesis was performed following
the same procedure as for compound 2, using 1 equiv of 8-Br-dGuo, 5
equiv of spermidine, and 5 equiv of triethylamine. The crude material
was purified by HPLC, as described for compound 2, with a gradient
of eluent B from 0 to 12% over 20 min. The two products 3a and 3b
which eluted at 14.3 min (k′ = 3.21) and 15.7 min (k′ = 3.62),
respectively, were collected. The two isomers exhibit identical 1H
NMR spectral features: 1H NMR (D2O, 500 MHz, δ): 1.76−1.80 (m,
3H, Hspd), 2.06−2.12 (m, 3H, Hspd), 2.34 (ddd, 1H, J = 2.2, 6.1, 14.3
Hz, H2′′), 2.74 (ddd, 1H, J = 6.5, 9.1, 14.3 Hz, H2′), 3.09−3.12 (m,
4H, Hspd), 3.14−3.18 (m, 2H, HspdG), 3.44−3.47 (m, 2H, HspdA), 3.88
(dd, 1H, J = 2.8, 12.4 Hz, H5′′), 3.94 (dd, 1H, J = 2.1, 12.4 Hz, H5′),
4.19−4.20 (m, 1H, H4′), 4.63−4.66 (m, 1H, H3′), 6.42 (dd, 1H, J =
6.1, 9.1 Hz, H1′). MALDI-HRMS m/z for C17H31N8O4+ ([M + H]+):
calcd 411.2468; found 411.2534.
EXPERIMENTAL PROCEDURES
■
Chemicals. N-Bromosuccinimide, 1,4-diaminobutane (putrescine),
spermidine, spermine, triethylamine, and solvents for organic synthesis
were purchased from Sigma-Aldrich (St. Louis, MO). 2′-Deoxygua-
nosine (dGuo) and 2′-deoxythymidine were obtained from Pharma
8-((3-((4-((3-Aminopropyl)amino)butyl)amino)propyl)amino)-2′-
deoxyguanosine (8-spm-dGuo, 4). The synthesis was performed
following the same procedure as that for compound 2, using 1 equiv of
8-Br-dGuo, 5 equiv of spermine, and 5 equiv of triethylamine. The
crude material was purified by HPLC, as described for compound 2,
with a gradient of eluent B from 0 to 14% over 21 min. The product
Waldhof (Dusseldorf, Germany), HPLC grade acetonitrile was
̈
purchased from VWR BDH Prolabo (Fontenay-sous-Bois, France)
and trifluoroacetic acid and heptafluorobutyric acid from Sigma-
Aldrich. Enzymes for DNA digestion (nuclease P1, phospodiesterase I
and II, and alkaline phosphatase) and calf thymus DNA were
purchased from Sigma-Aldrich. NMR solvents were obtained from
Euriso-top (Gif-sur-Yvette, France).
1
which eluted at 13.8 min (k′ = 3.06) was collected. H NMR (D2O,
500 MHz, δ): 1.36−1.39 (m, 4H, HspmE,F), 1.64−1.72 (m, 4H, HspmB,I),
1.94 (ddd, 1H, J = 2.0, 6.2, 14.3 Hz, H2′′), 2.35 (ddd, 4H, J = 6.3, 8.6,
14.3 Hz, H2′), 2.68−2.72 (m, 8H, HspmC,D,G,H), 2.74−2.77 (m, 2H,
HspmJ), 3.09−3.13 (m, 2H, HspmA), 3.48 (dd, J = 2.6, 12.4 Hz, H5′′),
Instrumentation. The HPLC-MS/MS analyses were performed
with a triple quadrupole mass spectrometer TSQ Quantum Ultra from
1012
dx.doi.org/10.1021/tx500063d | Chem. Res. Toxicol. 2014, 27, 1011−1018